Polyurea dendrimer folate-targeted nanodelivery of L-buthionine sulfoximine as a tool to tackle ovarian cancer chemoresistance
Grundy and Schemann, 2006)
Exceptions Certain conditions could preclude the use of tirzepatide, including a history of pancreatitis, medullary thyroid cancer, or severe gastrointestinal disorders
There is no single GLP-1 medication with universally fewer side effectstolerability varies significantly between individuals based on genetics, metabolic markers, and dosing approach
Tirzepatide targets GLP-1 and GIP receptors , while retatrutide adds glucagon receptor activation to that mechanism
Reviewed by Adam Gardner, Licensed Pharmacist Adam Gardner brings over 15 years of leadership experience in the pharmaceutical industry